LG 100069; LGD 1069; Ro 26-4455; SR 11247
153559-49-0
348.5
C24H28O2
DMF, DMSO
-20°C
Bexarotene is a synthetic retinoid analog with specific affinity for the retinoid X receptor and belongs to a group of compounds called rexinoids. It is an oral, noncytotoxic drug that was approved in Europe and in the U.S.A. for the treatment of refractory advanced-stage cutaneous T-cell lymphomas. The receptor-selective retinoids might be particularly useful in preventing ER-negative breast cancer.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
